title: Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.
authors.affiliation: Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY.
authors.forename: Emese
authors.initials: E
authors.lastname: Zsiros
authors.affiliation: Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY.
authors.forename: Takemasa
authors.initials: T
authors.lastname: Tsuji
authors.affiliation: Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY kunle.odunsi@roswellpark.org.
authors.forename: Kunle
authors.initials: K
authors.lastname: Odunsi
mesh_terms: D052685:Alphapapillomavirus; D005260:Female; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000628:therapy*